Integrated data analysis reveals potential drivers and pathways disrupted by DNA methylation in papillary thyroid carcinomas
出版年份 2017 全文链接
标题
Integrated data analysis reveals potential drivers and pathways disrupted by DNA methylation in papillary thyroid carcinomas
作者
关键词
Papillary thyroid cancer, DNA methylation, Integrative analysis, FGF signaling pathway, Retinoic acid pathway, <em class=EmphasisTypeItalic >BRAF</em>V600E mutation
出版物
Clinical Epigenetics
Volume 9, Issue 1, Pages -
出版商
Springer Nature
发表日期
2017-05-02
DOI
10.1186/s13148-017-0346-2
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Epigenetic Alterations and Canonical Pathway Disruption in Papillary Thyroid Cancer: A Genome-wide Methylation Analysis
- (2016) Michael G. White et al. ANNALS OF SURGICAL ONCOLOGY
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Performance evaluation of the touchscreen-based Muse™ Auto CD4/CD4% single-platform system for CD4 T cell numeration in absolute number and in percentage using blood samples from children and adult patients living in the Central African Republic
- (2016) Christian Diamant Mossoro-Kpinde et al. Journal of Translational Medicine
- Biologic and Clinical Perspectives on Thyroid Cancer
- (2016) James A. Fagin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical Manifestations and Gene Expression in Patients with Conventional Papillary Thyroid Carcinoma Carrying theBRAFV600EMutation andBRAF Pseudogene
- (2016) Jiunn-Diann Lin et al. THYROID
- Tobacco smoking-associated genome-wide DNA methylation changes in the EPIC study
- (2016) Srikant Ambatipudi et al. Epigenomics
- Effect of BRAF mutational status on expression profiles in conventional papillary thyroid carcinomas
- (2015) Hans-Juergen Schulten et al. BMC GENOMICS
- High Diagnostic Accuracy Based onCLDN10,HMGA2, andLAMB3Transcripts in Papillary Thyroid Carcinoma
- (2015) Mateus Camargo Barros-Filho et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- limma powers differential expression analyses for RNA-sequencing and microarray studies
- (2015) Matthew E. Ritchie et al. NUCLEIC ACIDS RESEARCH
- The Risk of Relapse in Papillary Thyroid Cancer (PTC) in the Context of BRAFV600E Mutation Status and Other Prognostic Factors
- (2015) Agnieszka Czarniecka et al. PLoS One
- Integrated Genomic Characterization of Papillary Thyroid Carcinoma
- (2014) Nishant Agrawal et al. CELL
- Molecular Pathways: HER3 Targeted Therapy
- (2014) K. Gala et al. CLINICAL CANCER RESEARCH
- DNA methylation profiling of well-differentiated thyroid cancer uncovers markers of recurrence free survival
- (2014) Veronika Mancikova et al. INTERNATIONAL JOURNAL OF CANCER
- TERTPromoter Mutations and Their Association withBRAFV600E Mutation and Aggressive Clinicopathological Characteristics of Thyroid Cancer
- (2014) Xiaoli Liu et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The high mobility group A2 protein epigenetically silences the Cdh1 gene during epithelial-to-mesenchymal transition
- (2014) E-Jean Tan et al. NUCLEIC ACIDS RESEARCH
- Altered Expression of Multiple Genes Involved in Retinoic Acid Biosynthesis in Human Colorectal Cancer
- (2014) Ekaterina S. Kropotova et al. PATHOLOGY & ONCOLOGY RESEARCH
- DNA Methylation of Transcriptional Enhancers and Cancer Predisposition
- (2013) Dvir Aran et al. CELL
- DNA Methylation Signatures Identify Biologically Distinct Thyroid Cancer Subtypes
- (2013) Sandra Rodríguez-Rodero et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Genome-Wide Methylation Patterns in Papillary Thyroid Cancer Are Distinct Based on Histological Subtype and Tumor Genotype
- (2013) Ryan J. Ellis et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Melanoma adapts to RAF/MEK inhibitors through FOXD3-mediated upregulation of ERBB3
- (2013) Ethan V. Abel et al. JOURNAL OF CLINICAL INVESTIGATION
- Progress in molecular-based management of differentiated thyroid cancer
- (2013) Mingzhao Xing et al. LANCET
- Relief of Feedback Inhibition of HER3 Transcription by RAF and MEK Inhibitors Attenuates Their Antitumor Effects in BRAF -Mutant Thyroid Carcinomas
- (2013) Cristina Montero-Conde et al. Cancer Discovery
- Aberrantly methylated genes in human papillary thyroid cancer and their association with BRAF/RAS mutation
- (2013) Yasuko Kikuchi et al. Frontiers in Genetics
- Correlation between BRAF mutation and promoter methylation of TIMP3, RARβ2 and RASSF1A in thyroid cancer
- (2012) Mariana Brait et al. Epigenetics
- BRAFV600E Mutation Does Not Mean Distant Metastasis in Thyroid Papillary Carcinomas
- (2012) Valentina Sancisi et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Functions of DNA methylation: islands, start sites, gene bodies and beyond
- (2012) Peter A. Jones NATURE REVIEWS GENETICS
- Is the BRAFV600E mutation useful as a predictor of preoperative risk in papillary thyroid cancer?
- (2011) Jung Kwang Nam et al. AMERICAN JOURNAL OF SURGERY
- Alcohol and aldehyde dehydrogenases: Retinoid metabolic effects in mouse knockout models
- (2011) Sandeep Kumar et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- The association of the BRAFV600E mutation with prognostic factors and poor clinical outcome in papillary thyroid cancer
- (2011) Tae Hyuk Kim et al. CANCER
- Role of BRAF in Thyroid Oncogenesis
- (2011) L. M. Caronia et al. CLINICAL CANCER RESEARCH
- Diagnostic and Prognostic Markers in Differentiated Thyroid Cancer
- (2011) Jose M. Gomez Saez CURRENT GENOMICS
- Genome-wide alterations in gene methylation by the BRAF V600E mutation in papillary thyroid cancer cells
- (2011) Peng Hou et al. ENDOCRINE-RELATED CANCER
- Validation of a DNA methylation microarray for 450,000 CpG sites in the human genome
- (2011) Juan Sandoval et al. Epigenetics
- Quantity Control of the ErbB3 Receptor Tyrosine Kinase at the Endoplasmic Reticulum
- (2011) W. H. D. Fry et al. MOLECULAR AND CELLULAR BIOLOGY
- Epigenome Mapping in Normal and Disease States
- (2010) Alika K. Maunakea et al. CIRCULATION RESEARCH
- Gender is an Age-Specific Effect Modifier for Papillary Cancers of the Thyroid Gland
- (2009) B. A. Kilfoy et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Redifferentiation Therapy with 13-cis Retinoic Acids in Radioiodine-Resistant Thyroid Cancer
- (2009) Won Gu KIM et al. ENDOCRINE JOURNAL
- Lineage-specific DNA methylation in T cells correlates with histone methylation and enhancer activity
- (2009) C. Schmidl et al. GENOME RESEARCH
- HMGA2 mRNA expression correlates with the malignant phenotype in human thyroid neoplasias
- (2008) Gennaro Chiappetta et al. EUROPEAN JOURNAL OF CANCER
- Retinoic acid in development: towards an integrated view
- (2008) Karen Niederreither et al. NATURE REVIEWS GENETICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started